Healthcare data company ConcertAI announced a multi-year agreement with pharmaceutical and biotechnology giant Bayer to utilize ConcertAI's Translational360 and AI SaaS offerings.
The offerings use AI- and machine learning-acquired insights to speed up clinical development in precision oncology.
The agreement aims to utilize ConcertAI's Translational360 offering, an integrated research-level...
Biotechnology and precision medicine company Caris Life Sciences announced it raised $168 million in growth capital funding.
Caris Life Sciences has now raised $1.86 billion in capital since 2018.
Braidwell LP led the round with participation from new investors Perceptive Advisors, Woodline and Ghisallo.
Millennium Management and First Light Asset Management also participated in the round.
WHAT...
Genome British Columbia (Genome BC), a not-for-profit genomics research company, has secured $49 million in funding for five projects that will be conducted in British Columbia and will utilize genomics to advance personalized healthcare.
According to Genome BC, the projects are part of research funding announced in March by Genome Canada under the Canadian Precision Health Initiative (CPHI). ...
Engineers from the University of Hong Kong have developed a generative AI-based imaging method that supports cancer diagnosis.
HOW IT WORKS
CytoMAD (Cyto-Morphology Adversarial Distillation) combines AI and microfluidic technology to do label-free imaging of tumours at the individual cell level. It can capture cell images "at great speed, enhance these images, and automatically correct...
Google announced it is partnering with the Institute of Women's Cancers, founded by France's cancer research and treatment center, Institut Curie, to study how AI tools can help address cancer, share science-based health information and support postdoctoral researchers with funding.
The partnership, which was announced at the France AI Action Summit, combines Institut Curie’s proficiency in...
MediBuddy developing IoT devices with Japan's ELECOM
Virtual care company MediBuddy has started collaborating with Japanese electronics maker ELECOM to develop health IoT devices.
In a media release, MediBuddy said it will develop products for daily health management and leverage the collected health and medical data to generate personalised health insights and preventive care programmes.
"In...
A new company under financial investment firm SOL Partnership has launched what could be the first at-home gut health test service powered by AI in Malaysia.
SpaceGut offers an at-home gut microbiome kit and a laboratory service that provides personalised recommendations for an individual's gut health. Leveraging a proprietary AI, its laboratory evaluates samples compared against a database of...
Lunit collabs with AstraZeneca, secures major deal in France
Lunit and AstraZeneca have partnered to develop new AI-powered digital pathology solutions that predict non-small cell lung cancer (NSCLC).
Based on a media release, their collaboration aims to accelerate the time-consuming process of genomic testing as part of NSCLC identification and diagnosis by leveraging Lunit's AI. The latter's...
A consortium of research institutes in South Korea has been formed to promote the utilisation of AI and national supercomputers in discovering novel drugs for treating lung cancer.
According to a press statement, the following organisations will collaborate to develop and test AI for identifying novel drug candidates and predicting its efficacy:
DAAN Cancer Research Institute under Yonsei...
ImpriMed, a precision medicine company, announced that it has expanded its services to include human oncology.
The aim is to provide drug-response predictions for routine blood cancers such as newly diagnosed multiple myeloma and acute myeloid leukemia.
ImpriMed's human precision medicine services will set their sights on complex blood cancers via a combination of genomic analysis, ex vivo drug...
